lonafarnib has been researched along with anisomycin in 1 studies
| Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (anisomycin) | Trials (anisomycin) | Recent Studies (post-2010) (anisomycin) |
|---|---|---|---|---|---|
| 224 | 34 | 90 | 1,357 | 0 | 319 |
| Protein | Taxonomy | lonafarnib (IC50) | anisomycin (IC50) |
|---|---|---|---|
| Glucose transporter | Leishmania mexicana | 0.225 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.326 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.321 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankri, S; Debnath, A; Rodriguez, MA | 1 |
1 other study(ies) available for lonafarnib and anisomycin
| Article | Year |
|---|---|
Editorial: Recent Progresses in Amebiasis.
Topics: Amebicides; Anisomycin; Asymptomatic Diseases; Drug Discovery; Dysentery, Amebic; Entamoeba histolytica; Flavonoids; Gene Expression Regulation; Humans; Life Cycle Stages; Metabolic Networks and Pathways; Metronidazole; Piperidines; Prodigiosin; Protozoan Proteins; Pyridines; Severity of Illness Index | 2019 |